Opposition · USPTO

Opposition 91250511

OtherUSPTO

Opposition 91250511 at USPTO between Neurocrine Biosciences, Inc. and Fnm Corporation Ltd. DBA TA Francemed Pharma, over the mark NEUROCURE, filed Aug 28, 2019. Status in the office record: other.

View NEUROCUREGet this data via the API
Status
Other
Result
Other
Filed
Aug 28, 2019
Marks involved
5
Parties

Who is involved

The parties as named in the office record.

Opponent

Neurocrine Biosciences, Inc.

Respondent

Fnm Corporation Ltd. DBA TA Francemed Pharma

Timeline

How the case has moved

Dates from the USPTO record and the NEUROCURE filing.

  1. NEUROCURE filed

    Application 88234933 filed at the USPTO.

  2. Opposition filed

    Neurocrine Biosciences, Inc. started opposition 91250511 at USPTO against NEUROCURE.
Marks

Marks involved

1 contested mark, 4 marks the challenger relies on.

MarkRoleApplicationOffice
NEUROCUREContested88234933USPTO
NEUROCRINE BIOSCIENCESRelied on75783701USPTO
NEUROCRINE BIOSCIENCESRelied on75783702USPTO
NEUROCRINERelied on88155421USPTO
NEUROCRINERelied on88155436USPTO
API

Get this data via the API

Every fact on this page comes from the Signa API. Track oppositions and cancellations on any mark with one request.

  • GET/v1/proceedings/{id}

    Parties, dates, outcome and every mark in the case

  • GET/v1/proceedings?trademark_id={trademark_id}

    Every proceeding on a mark

Get API keyView docs
GET /v1/proceedings/{id}
ID=prc_47798e07-8b89-4870-be87-01d6ff495c6f
curl https://api.signa.so/v1/proceedings/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "prc_47798e07-8b89-4870-be87-01d6ff495c6f",
  "object": "proceeding",
  "proceeding_type": "opposition",
  "proceeding_number": "91250511",
  "status": "other",
  "office_code": "US",
  "filed_date": "2019-08-28",
  "parties": [
    {
      "name": "Neurocrine Biosciences, Inc.",
      "role": "opponent"
    },
    {
      "name": "Fnm Corporation Ltd. DBA TA Francemed Pharma",
      "role": "respondent"
    }
  ]
}